BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26345861)

  • 1. Relationship of the APOA5/A4/C3/A1 gene cluster and APOB gene polymorphisms with dyslipidemia.
    Ou HJ; Huang G; Liu W; Ma XL; Wei Y; Zhou T; Pan ZM
    Genet Mol Res; 2015 Aug; 14(3):9277-90. PubMed ID: 26345861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
    Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
    PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
    Yin RX; Li YY; Lai CQ
    Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
    Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
    Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between apolipoprotein A1-C3-A5 gene cluster promoter polymorphisms and risk of ischemic stroke in the northern Chinese Han population.
    Wang Y; Liu F; Li L; Deng S; He Z
    J Int Med Res; 2017 Dec; 45(6):2042-2052. PubMed ID: 28635360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Eight Functional Polymorphisms and Haplotypes in the Cholesterol Ester Transfer Protein (CETP) Gene and Dyslipidemia in National Minority Adults in the Far West Region of China.
    Guo S; Hu Y; Ding Y; Liu J; Zhang M; Ma R; Guo H; Wang K; He J; Yan Y; Rui D; Sun F; Mu L; Niu Q; Zhang J; Li S
    Int J Environ Res Public Health; 2015 Dec; 12(12):15979-92. PubMed ID: 26694435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
    Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
    Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the apolipoprotein a1/c3/a5 haplotypes and alcohol consumption on serum lipid levels.
    Yin RX; Li YY; Wu JZ; Pan SL; Liu CW; Lin WX; Yang DZ
    Alcohol Clin Exp Res; 2013 Feb; 37(2):234-43. PubMed ID: 22924697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
    Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
    Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional polymorphisms of the APOA1/C3/A4/A5-ZPR1-BUD13 gene cluster are associated with dyslipidemia in a sex-specific pattern.
    Bai W; Kou C; Zhang L; You Y; Yu W; Hua W; Li Y; Yu Y; Zhao T; Wu Y
    PeerJ; 2019; 6():e6175. PubMed ID: 30631647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying functional non-coding variants in APOA5/A4/C3/A1 gene cluster associated with coronary heart disease.
    Cui G; Tian M; Hu S; Wang Y; Wang DW
    J Mol Cell Cardiol; 2020 Jul; 144():54-62. PubMed ID: 32437778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population.
    Chien KL; Chen MF; Hsu HC; Su TC; Chang WT; Lee CM; Lee YT
    Clin Chim Acta; 2008 Feb; 388(1-2):78-83. PubMed ID: 17964293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
    Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
    Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.
    Liu ZK; Hu M; Baum L; Thomas GN; Tomlinson B
    Atherosclerosis; 2010 Feb; 208(2):427-32. PubMed ID: 19732897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
    Qi L; Liu S; Rifai N; Hunter D; Hu FB
    Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome.
    Ding Y; Zhu MA; Wang ZX; Zhu J; Feng JB; Li DS
    J Biomed Biotechnol; 2012; 2012():509420. PubMed ID: 22675253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men.
    Liu S; Song Y; Hu FB; Niu T; Ma J; Gaziano M; Stampfer MJ
    Atherosclerosis; 2004 Nov; 177(1):119-26. PubMed ID: 15488874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
    Int J Mol Med; ; . PubMed ID: 22576629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.